These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11795516)

  • 1. Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
    Kitani K; Minami C; Yamamoto T; Maruyama W; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 2001 Apr; 928():248-60. PubMed ID: 11795516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl: a possible antioxidant strategy.
    Kitani K; Kanai S; Ivy GO; Carrillo MC
    Mech Ageing Dev; 1999 Nov; 111(2-3):211-21. PubMed ID: 10656538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of (-)deprenyl.
    Kitani K; Minami C; Maruyama W; Kanai S; Ivy GO; Carrillo MC
    J Neural Transm Suppl; 2000; (60):139-56. PubMed ID: 11205136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why (--)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects.
    Kitani K; Minami C; Isobe K; Maehara K; Kanai S; Ivy GO; Carrillo MC
    Mech Ageing Dev; 2002 Apr; 123(8):1087-100. PubMed ID: 12044958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models.
    Kitani K; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 1998 Nov; 854():291-306. PubMed ID: 9928438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use.
    Kitani K; Minami C; Yamamoto T; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 2002 Apr; 959():295-307. PubMed ID: 11976204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Miyasaka K; Ivy GO
    Life Sci; 1994; 54(14):975-81. PubMed ID: 8139387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat.
    Carrillo MC; Minami C; Kitani K; Maruyama W; Ohashi K; Yamamoto T; Naoi M; Kanai S; Youdim MB
    Life Sci; 2000 Jun; 67(5):577-85. PubMed ID: 10993123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacopa monnieri and L-deprenyl differentially enhance the activities of antioxidant enzymes and the expression of tyrosine hydroxylase and nerve growth factor via ERK 1/2 and NF-κB pathways in the spleen of female wistar rats.
    Priyanka HP; Bala P; Ankisettipalle S; ThyagaRajan S
    Neurochem Res; 2013 Jan; 38(1):141-52. PubMed ID: 23076629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
    Seif-El-Nasr M; Atia AS; Abdelsalam RM
    Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Ivy GO; Miyasaka K
    Life Sci; 1996; 59(13):1047-57. PubMed ID: 8809224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats.
    Carrillo MC; Kanai S; Sato Y; Nokubo M; Ivy GO; Kitani K
    Life Sci; 1993; 52(24):1925-34. PubMed ID: 8505859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Ivy GO
    Life Sci; 1992; 50(25):1985-92. PubMed ID: 1593926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The necessity of having a proper dose of (-)deprenyl (D) to prolong the life spans of rats explains discrepancies among different studies in the past.
    Kitani K; Kanai S; Miyasaka K; Carrillo MC; Ivy GO
    Ann N Y Acad Sci; 2006 May; 1067():375-82. PubMed ID: 16804014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAO inhibitors and oxidant stress in aging brain tissue.
    Alper G; Girgin FK; Ozgönül M; Menteş G; Ersöz B
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):247-52. PubMed ID: 10208295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high dose of long term treatment with deprenyl loses its effect on antioxidant enzyme activities as well as on survivals of Fischer-344 rats.
    Carrillo MC; Kanai S; Kitani K; Ivy GO
    Life Sci; 2000 Oct; 67(21):2539-48. PubMed ID: 11104356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats.
    Carrillo MC; Kitani K; Kanai S; Sato Y; Miyasaka K; Ivy GO
    Biochem Pharmacol; 1994 Apr; 47(8):1333-8. PubMed ID: 8185641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.
    Vizuete ML; Steffen V; Ayala A; Cano J; Machado A
    Neurosci Lett; 1993 Apr; 152(1-2):113-6. PubMed ID: 8515861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.